Role of the pathologist in active surveillance for prostate cancer

Roberta Mazzucchelli, Andrea B. Galosi, Matteo Santoni, Antonio Lopez-Beltran, Marina Scarpelli, Liang Cheng, Rodolfo Montironi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Active surveillance (AS) is an alternative strategy that aims to minimize overtreatment by selecting only patients with significant prostate cancer (PCa) tumors for immediate treatment. Patients with favorable tumor characteristics are closely monitored using serum prostatespecific antigen (PSA) levels and serial biopsies of the prostate. In addition, other predictors of tumor progression, such as PSA doubling time, can be used during AS management. AS represents an excellent opportunity to identify molecular biomarkers of PCa behavior and to develop novel therapeutic strategies.

Original languageEnglish
Pages (from-to)65-68
Number of pages4
JournalAnalytical and Quantitative Cytology and Histology
Volume37
Issue number1
StatePublished - 2015

Fingerprint

Prostatic Neoplasms
Antigens
Neoplasms
Prostate
Biomarkers
Biopsy
Therapeutics
Serum
Pathologists
Medical Overuse

Keywords

  • Active surveillance
  • Immunohistochemistry
  • Prostate biopsy
  • Prostate cancer
  • Tumor extent

ASJC Scopus subject areas

  • Anatomy
  • Histology
  • Medicine(all)

Cite this

Mazzucchelli, R., Galosi, A. B., Santoni, M., Lopez-Beltran, A., Scarpelli, M., Cheng, L., & Montironi, R. (2015). Role of the pathologist in active surveillance for prostate cancer. Analytical and Quantitative Cytology and Histology, 37(1), 65-68.

Role of the pathologist in active surveillance for prostate cancer. / Mazzucchelli, Roberta; Galosi, Andrea B.; Santoni, Matteo; Lopez-Beltran, Antonio; Scarpelli, Marina; Cheng, Liang; Montironi, Rodolfo.

In: Analytical and Quantitative Cytology and Histology, Vol. 37, No. 1, 2015, p. 65-68.

Research output: Contribution to journalArticle

Mazzucchelli, R, Galosi, AB, Santoni, M, Lopez-Beltran, A, Scarpelli, M, Cheng, L & Montironi, R 2015, 'Role of the pathologist in active surveillance for prostate cancer', Analytical and Quantitative Cytology and Histology, vol. 37, no. 1, pp. 65-68.
Mazzucchelli R, Galosi AB, Santoni M, Lopez-Beltran A, Scarpelli M, Cheng L et al. Role of the pathologist in active surveillance for prostate cancer. Analytical and Quantitative Cytology and Histology. 2015;37(1):65-68.
Mazzucchelli, Roberta ; Galosi, Andrea B. ; Santoni, Matteo ; Lopez-Beltran, Antonio ; Scarpelli, Marina ; Cheng, Liang ; Montironi, Rodolfo. / Role of the pathologist in active surveillance for prostate cancer. In: Analytical and Quantitative Cytology and Histology. 2015 ; Vol. 37, No. 1. pp. 65-68.
@article{58e3aab6bb214bbf8e5b7cd21be28659,
title = "Role of the pathologist in active surveillance for prostate cancer",
abstract = "Active surveillance (AS) is an alternative strategy that aims to minimize overtreatment by selecting only patients with significant prostate cancer (PCa) tumors for immediate treatment. Patients with favorable tumor characteristics are closely monitored using serum prostatespecific antigen (PSA) levels and serial biopsies of the prostate. In addition, other predictors of tumor progression, such as PSA doubling time, can be used during AS management. AS represents an excellent opportunity to identify molecular biomarkers of PCa behavior and to develop novel therapeutic strategies.",
keywords = "Active surveillance, Immunohistochemistry, Prostate biopsy, Prostate cancer, Tumor extent",
author = "Roberta Mazzucchelli and Galosi, {Andrea B.} and Matteo Santoni and Antonio Lopez-Beltran and Marina Scarpelli and Liang Cheng and Rodolfo Montironi",
year = "2015",
language = "English",
volume = "37",
pages = "65--68",
journal = "Analytical and Quantitative Cytopathology and Histopathology",
issn = "0301-102X",
publisher = "John Rylands University Library",
number = "1",

}

TY - JOUR

T1 - Role of the pathologist in active surveillance for prostate cancer

AU - Mazzucchelli, Roberta

AU - Galosi, Andrea B.

AU - Santoni, Matteo

AU - Lopez-Beltran, Antonio

AU - Scarpelli, Marina

AU - Cheng, Liang

AU - Montironi, Rodolfo

PY - 2015

Y1 - 2015

N2 - Active surveillance (AS) is an alternative strategy that aims to minimize overtreatment by selecting only patients with significant prostate cancer (PCa) tumors for immediate treatment. Patients with favorable tumor characteristics are closely monitored using serum prostatespecific antigen (PSA) levels and serial biopsies of the prostate. In addition, other predictors of tumor progression, such as PSA doubling time, can be used during AS management. AS represents an excellent opportunity to identify molecular biomarkers of PCa behavior and to develop novel therapeutic strategies.

AB - Active surveillance (AS) is an alternative strategy that aims to minimize overtreatment by selecting only patients with significant prostate cancer (PCa) tumors for immediate treatment. Patients with favorable tumor characteristics are closely monitored using serum prostatespecific antigen (PSA) levels and serial biopsies of the prostate. In addition, other predictors of tumor progression, such as PSA doubling time, can be used during AS management. AS represents an excellent opportunity to identify molecular biomarkers of PCa behavior and to develop novel therapeutic strategies.

KW - Active surveillance

KW - Immunohistochemistry

KW - Prostate biopsy

KW - Prostate cancer

KW - Tumor extent

UR - http://www.scopus.com/inward/record.url?scp=84925355972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925355972&partnerID=8YFLogxK

M3 - Article

C2 - 26072636

AN - SCOPUS:84925355972

VL - 37

SP - 65

EP - 68

JO - Analytical and Quantitative Cytopathology and Histopathology

JF - Analytical and Quantitative Cytopathology and Histopathology

SN - 0301-102X

IS - 1

ER -